$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023037682 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$110.0K	$87.00K	$234.0K
YoY Change		-62.82%
Cost Of Revenue	$10.00K
YoY Change
Gross Profit	$100.0K
YoY Change
Gross Profit Margin	90.91%
Selling, General & Admin	$3.120M	$3.020M	$4.553M
YoY Change	-11.39%	-33.67%	-30.58%
% of Gross Profit	3120.0%
Research & Development	$4.000M	$4.333M	$6.273M
YoY Change	-25.93%	-30.93%	-19.82%
% of Gross Profit	4000.0%
Depreciation & Amortization	$70.00K	$88.00K	$251.0K
YoY Change	-49.28%	-64.94%	-75.73%
% of Gross Profit	70.0%
Operating Expenses	$6.650M	$4.333M	$10.71M
YoY Change	-25.13%	-59.54%	-24.72%
Operating Profit	-$6.550M	-$7.100M	-$10.48M
YoY Change		-32.22%	-26.36%
Interest Expense	-$60.00K	-$217.0K	$557.0K
YoY Change	-70.3%	-138.96%	-2020.69%
% of Operating Profit
Other Income/Expense, Net		-$441.0K
YoY Change
Pretax Income	-$6.610M	-$7.758M	-$9.918M
YoY Change	-27.23%	-21.78%	-30.42%
Income Tax
% Of Pretax Income
Net Earnings	-$6.610M	-$7.624M	-$9.918M
YoY Change	-27.23%	-23.13%	-30.42%
Net Earnings / Revenue	-6009.09%	-8763.22%	-4238.46%
Basic Earnings Per Share		-$0.19	-$0.31
Diluted Earnings Per Share	-$0.16	-$0.19	-$307.4K
COMMON SHARES
Basic Shares Outstanding	41.12M shares	39.81M shares	32.26M shares
Diluted Shares Outstanding		39.95M shares	32.26M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.17M	$44.17M	$61.98M
YoY Change	-26.98%	-28.74%	30.84%
Cash & Equivalents	$5.360M	$3.677M	$23.79M
Short-Term Investments	$34.81M	$40.49M	$38.19M
Other Short-Term Assets	$1.130M	$2.519M	$2.333M
YoY Change	-58.62%	7.97%	-4.78%
Inventory
Prepaid Expenses	$442.0K
Receivables
Other Receivables
Total Short-Term Assets	$41.41M	$46.69M	$64.31M
YoY Change	-28.29%	-27.41%	29.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$688.0K	$681.0K	$9.140M
YoY Change	-6.9%	-92.55%	236.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$4.235M
YoY Change			-83.67%
Other Assets	$1.000K	$2.000K	$1.439M
YoY Change	-92.86%	-99.86%	104.4%
Total Long-Term Assets	$9.388M	$9.554M	$14.81M
YoY Change	-9.01%	-35.51%	-49.53%
TOTAL ASSETS
Total Short-Term Assets	$41.41M	$46.69M	$64.31M
Total Long-Term Assets	$9.388M	$9.554M	$14.81M
Total Assets	$50.80M	$56.24M	$79.13M
YoY Change	-25.37%	-28.92%	-0.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.810M	$1.453M	$3.942M
YoY Change	1.4%	-63.14%	86.82%
Accrued Expenses	$1.209M	$1.335M	$3.880M
YoY Change	-25.83%	-65.59%	-30.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.621M	$5.377M	$7.822M
YoY Change	-17.69%	-31.26%	-21.12%
LONG-TERM LIABILITIES
Long-Term Debt	$23.53M	$23.35M	$22.92M
YoY Change	8.54%	1.84%
Other Long-Term Liabilities	$6.350M	$6.637M	$8.238M
YoY Change	-13.86%	-19.43%	634.22%
Total Long-Term Liabilities	$29.88M	$29.98M	$31.16M
YoY Change	2.84%	-3.78%	2677.36%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.621M	$5.377M	$7.822M
Total Long-Term Liabilities	$29.88M	$29.98M	$31.16M
Total Liabilities	$35.50M	$35.36M	$41.03M
YoY Change	-1.06%	-13.83%	271.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$399.6M	-$393.1M
YoY Change	7.63%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.36M	$19.06M	$38.09M
YoY Change
Total Liabilities & Shareholders Equity	$50.80M	$56.24M	$79.13M
YoY Change	-25.37%	-28.92%	-0.06%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$6.610M	-$7.624M	-$9.918M
YoY Change	-27.23%	-23.13%	-30.42%
Depreciation, Depletion And Amortization	$70.00K	$88.00K	$251.0K
YoY Change	-49.28%	-64.94%	-75.73%
Cash From Operating Activities	-$2.900M	-$6.071M	-$9.422M
YoY Change	-65.59%	-35.57%	-55.79%
INVESTING ACTIVITIES
Capital Expenditures	$90.00K	$24.00K	-$37.00K
YoY Change	-145.23%	-164.86%	-88.82%
Acquisitions
YoY Change
Other Investing Activities	$4.420M	-$1.664M	$7.700M
YoY Change	-260.38%	-121.61%	-165.67%
Cash From Investing Activities	$4.330M	-$1.688M	$7.663M
YoY Change	-246.53%	-122.03%	-163.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	2.341M	7.500M
YoY Change		-68.79%	-79.73%
NET CHANGE
Cash From Operating Activities	-2.900M	-6.071M	-9.422M
Cash From Investing Activities	4.330M	-1.688M	7.663M
Cash From Financing Activities	-10.00K	2.341M	7.500M
Net Change In Cash	1.420M	-5.418M	5.741M
YoY Change	-112.48%	-194.37%	58.5%
FREE CASH FLOW
Cash From Operating Activities	-$2.900M	-$6.071M	-$9.422M
Capital Expenditures	$90.00K	$24.00K	-$37.00K
Free Cash Flow	-$2.990M	-$6.095M	-$9.385M
YoY Change	-63.66%	-35.06%	-55.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	City Area Code CityAreaCode	972
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.00
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-31392
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0351734
	dei	Entity Address Address Line1 EntityAddressAddressLine1	MATAM Advanced Technology Park
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building No. 5
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Address City Or Town EntityAddressCityOrTown	Haifa
	dei	Entity Address Country EntityAddressCountry	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	3508409
	dei	Security12b Title Security12bTitle	Common Shares, par value $0.00001
	dei	Trading Symbol TradingSymbol	PLUR
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41118442	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3677000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9772000	usd
CY2023Q1	plur	Shortterm Bank Deposits ShorttermBankDeposits	40491000	usd
CY2022Q2	plur	Shortterm Bank Deposits ShorttermBankDeposits	45244000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	273000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	1007000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2246000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1724000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	46687000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	57747000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	633000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	634000	usd
CY2023Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	437000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	661000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	681000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	739000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7801000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8270000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	9554000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	10318000	usd
CY2023Q1	us-gaap	Assets Assets	56241000	usd
CY2022Q2	us-gaap	Assets Assets	68065000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1453000	usd
CY2022Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1785000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1335000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1630000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	627000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	619000	usd
CY2023Q1	plur	Accrued Vacations Current AccruedVacationsCurrent	810000	usd
CY2022Q2	plur	Accrued Vacations Current AccruedVacationsCurrent	1053000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1152000	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1742000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5377000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6829000	usd
CY2023Q1	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	610000	usd
CY2022Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	867000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6027000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6505000	usd
CY2023Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	23346000	usd
CY2022Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	21678000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29983000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29050000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41072224	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41072224	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32507491	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32507491	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	412189000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	401302000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-393125000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-371263000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	19064000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	30039000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	1817000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	2147000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20881000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56241000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68065000	usd
	us-gaap	Revenues Revenues	176000	usd
	us-gaap	Revenues Revenues	234000	usd
CY2023Q1	us-gaap	Revenues Revenues	87000	usd
CY2022Q1	us-gaap	Revenues Revenues	234000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13412000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19205000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4333000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6273000	usd
	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1189000	usd
	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	189000	usd
CY2023Q1	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	166000	usd
CY2022Q1	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	117000	usd
	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	12223000	usd
	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	19016000	usd
CY2023Q1	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	4167000	usd
CY2022Q1	plur	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	6156000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8655000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13929000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3020000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4553000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20702000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-32711000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7100000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10475000	usd
	plur	Financial Expenses FinancialExpenses	623000	usd
	plur	Financial Expenses FinancialExpenses	676000	usd
CY2023Q1	plur	Financial Expenses FinancialExpenses	217000	usd
CY2022Q1	plur	Financial Expenses FinancialExpenses	223000	usd
	plur	Financial Income FinancialIncome	-956000	usd
	plur	Financial Income FinancialIncome	1097000	usd
CY2023Q1	plur	Financial Income FinancialIncome	-441000	usd
CY2022Q1	plur	Financial Income FinancialIncome	780000	usd
	plur	Financial Income Net FinancialIncomeNet	-1579000	usd
	plur	Financial Income Net FinancialIncomeNet	421000	usd
CY2023Q1	plur	Financial Income Net FinancialIncomeNet	-658000	usd
CY2022Q1	plur	Financial Income Net FinancialIncomeNet	557000	usd
	us-gaap	Profit Loss ProfitLoss	-22281000	usd
	us-gaap	Profit Loss ProfitLoss	-32290000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7758000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-9918000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-419000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-53000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-134000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-53000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21862000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-32237000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7624000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-9865000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35217037	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32131503	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39947602	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32261628	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57151000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57151000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57151000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7782000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7782000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7782000	usd
	plur	Establishment Of Ever After And Noncontrolling Interest In Ever After EstablishmentOfEverAfterAndNoncontrollingInterestInEverAfter	7500000	usd
	plur	Establishment Of Ever After And Noncontrolling Interest In Ever After EstablishmentOfEverAfterAndNoncontrollingInterestInEverAfter	7500000	usd
	plur	Establishment Of Ever After And Noncontrolling Interest In Ever After EstablishmentOfEverAfterAndNoncontrollingInterestInEverAfter	7500000	usd
	plur	Percentage Of Qualified Expenditures PercentageOfQualifiedExpenditures	0.50	pure
	us-gaap	Profit Loss ProfitLoss	-32290000	usd
	us-gaap	Profit Loss ProfitLoss	-32290000	usd
	us-gaap	Profit Loss ProfitLoss	-32290000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40143000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40143000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40143000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	39840000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2721000	usd
CY2022Q1	plur	Establishment Of Ever After And Noncontrolling Interest In Ever After EstablishmentOfEverAfterAndNoncontrollingInterestInEverAfter	7500000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-9918000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40143000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2942000	usd
	plur	Net Of Issuance Costs NetOfIssuanceCosts	435000	usd
	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	8034000	usd
	us-gaap	Profit Loss ProfitLoss	-22281000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20881000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24966000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24966000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24966000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1045000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1045000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1045000	usd
CY2023Q1	plur	Net Of Issuance Costs NetOfIssuanceCosts	74000	usd
CY2023Q1	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	2628000	usd
CY2023Q1	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	2628000	usd
CY2023Q1	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	2628000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7758000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7758000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7758000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20881000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20881000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20881000	usd
	us-gaap	Profit Loss ProfitLoss	-22281000	usd
	us-gaap	Profit Loss ProfitLoss	-32290000	usd
	us-gaap	Depreciation Depreciation	285000	usd
	us-gaap	Depreciation Depreciation	915000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2942000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7782000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	510000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	49000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-393000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-254000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1128000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3598000	usd
	plur	Decrease In Operating Lease Right Of Use Asset And Liability DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability	2000	usd
	plur	Decrease In Operating Lease Right Of Use Asset And Liability DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability	419000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	786000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	247000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	278000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1072000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1668000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-944000	usd
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-33000	usd
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-42000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19960000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28074000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	165000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	81000	usd
	plur	Proceeds From Withdrawal Of Shortterm Deposits ProceedsFromWithdrawalOfShorttermDeposits	5539000	usd
	plur	Proceeds From Withdrawal Of Shortterm Deposits ProceedsFromWithdrawalOfShorttermDeposits	-4233000	usd
	plur	Proceeds From Withdrawal Of Longterm Deposits ProceedsFromWithdrawalOfLongtermDeposits	19052000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5374000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14738000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8034000	usd
	plur	Proceeds Related To Investment In Subsidiary By Noncontrolling Interest ProceedsRelatedToInvestmentInSubsidiaryByNoncontrollingInterest	7500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8034000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7500000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-278000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1072000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6830000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6908000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11413000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31838000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4583000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24930000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	3677000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	23791000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	273000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	470000	usd
CY2023Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	633000	usd
CY2022Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	669000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4583000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24930000	usd
CY2023Q1	plur	Purchase Of Property And Equipment On Credit PurchaseOfPropertyAndEquipmentOnCredit	87000	usd
CY2022Q1	plur	Purchase Of Property And Equipment On Credit PurchaseOfPropertyAndEquipmentOnCredit	12000	usd
CY2022Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	187500	shares
CY2022Q1	plur	Additional Investment AdditionalInvestment	7500000	usd
	plur	Royalty Rate Sales RoyaltyRateSales	0.03	pure
	plur	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0325	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70	pure
	plur	Compensation Expense Recognized During The Period CompensationExpenseRecognizedDuringThePeriod	385000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>c.</i></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of estimates</i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -1.35pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p>
CY2023Q1	plur	Cash And Deposits CashAndDeposits	907000	usd
CY2023Q1	plur	Contingent Liability In Respect To Royalties ContingentLiabilityInRespectToRoyalties	27574000	usd
CY2020Q2	plur	Subsidiary Loan SubsidiaryLoan	50000000	eur
CY2020Q2	plur	Contract Period ContractPeriod	36 months
	plur	Contractual Interest Rate For Funds Borrowed ContractualInterestRateForFundsBorrowed	0.04	pure
	plur	Fixed Interest Rate FixedInterestRate	0	pure
	plur	Deferred Interest Rate Percentage DeferredInterestRatePercentage	0.04	pure
CY2021Q2	plur	First Tranche Price FirstTranchePrice	20000000	eur
CY2021Q2	plur	Annual Interest Percentage AnnualInterestPercentage	0.04	pure
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	21755000	usd
CY2023Q1	plur	Accrued Interest AccruedInterest	1591000	usd
CY2022Q3	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	11800	usd
CY2022Q4	plur	Aggregate Common Shares AggregateCommonShares	8155900	shares
CY2022Q4	plur	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	8155900	shares
CY2022Q4	us-gaap	Share Price SharePrice	1.03
CY2022Q4	plur	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	5579883	shares
CY2022Q4	plur	Purchase Of Common Shares PurchaseOfCommonShares	5579833	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.03
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.06
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.09
CY2022Q4	plur	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	135000	shares
CY2022Q4	plur	Purchase Of Common Shares PurchaseOfCommonShares	135000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.09
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.12
CY2022Q4	plur	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	135000	shares
CY2022Q4	plur	Purchase Of Common Shares PurchaseOfCommonShares	135000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.12
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	8155900	shares
	plur	Aggregate Gross Proceeds AggregateGrossProceeds	8000000	usd
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	435	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	5000	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	29000	usd
CY2023Q1	plur	General And Administration Income GeneralAndAdministrationIncome	1000	usd
CY2022Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	9000	usd
CY2022Q4	plur	Annual Cash Salary AnnualCashSalary	375000000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	334821	shares
	plur	Average Remaining Maturity Of Stock AverageRemainingMaturityOfStock	P3Y
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	310	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	310	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1935014	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2404415	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	334821	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	75000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	51389	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	41028	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	387583	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	350239	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1830866	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2088148	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1811309	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2052240	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1937000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	149000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	195000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
	us-gaap	Maturity Of Credit Risk Derivative MaturityOfCreditRiskDerivative	2023-10-16
	dei	Entity Registrant Name EntityRegistrantName	Pluri Inc.
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39947602	shares
	plur	Modification Of Warrants To Noncontrolling Interestsnote1c ModificationOfWarrantsToNoncontrollingInterestsnote1c		usd
	plur	Expiration Of Warrants ExpirationOfWarrants		usd
CY2023Q1	plur	Net Of Issuance Costs NetOfIssuanceCosts	74000	usd
CY2023Q1	plur	Net Of Issuance Costs NetOfIssuanceCosts	74000	usd
	plur	Proceeds From Withdrawal Of Longterm Deposits ProceedsFromWithdrawalOfLongtermDeposits		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001158780

Files In Submission

Name	View Source	Status
0001213900-23-037682-index-headers.html	Edgar Link	pending
0001213900-23-037682-index.html	Edgar Link	pending
0001213900-23-037682.txt	Edgar Link	pending
0001213900-23-037682-xbrl.zip	Edgar Link	pending
f10q0323ex3-1_pluriinc.htm	Edgar Link	pending
f10q0323ex3-2_pluriinc.htm	Edgar Link	pending
f10q0323ex31-1_pluriinc.htm	Edgar Link	pending
f10q0323ex31-2_pluriinc.htm	Edgar Link	pending
f10q0323ex32-1_pluriinc.htm	Edgar Link	pending
f10q0323ex32-2_pluriinc.htm	Edgar Link	pending
f10q0323_pluriinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
plur-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
plur-20230331_cal.xml	Edgar Link	unprocessable
plur-20230331_def.xml	Edgar Link	unprocessable
plur-20230331_lab.xml	Edgar Link	unprocessable
plur-20230331_pre.xml	Edgar Link	unprocessable
f10q0323_pluriinc_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2023 Q2 Form 10-Q Financial Statement

#000121390023037682 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2023 Q2 Form 10-Q Financial Statement

#000121390023037682 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur